Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 16, Number 11—November 2010

Enhanced Surveillance of Coccidioidomycosis, Arizona, USA, 2007–2008

Clarisse A. TsangComments to Author , Shoana M. Anderson, Sara B. Imholte, Laura M. Erhart, Sanny Chen, Benjamin J. Park, Cara Christ, Kenneth K. Komatsu, Tom M. Chiller, and Rebecca H. Sunenshine
Author affiliations: Arizona Department of Health Services, Phoenix, Arizona, USA (C.A. Tsang, S.M. Anderson, S.B. Imholte, L.M. Erhart, S. Chen, C. Christ, K.K. Komatsu, R.H. Sunenshine); Centers for Disease Control and Prevention, Atlanta, Georgia, USA (S. Chen, B.J. Park, T. Chiller, R.H. Sunenshine)

Main Article

Table 1

Demographic characteristics of reported coccidioidomycosis patients compared with enhanced surveillance patients, Arizona, USA, January 2007–February 2008

Characteristic Total reported, N = 5,664 Enhanced surveillance, n = 493 p value
Male sex, no. (%)* 3,003 (54) 259 (54) 0.7
Age, y
Mean 51 52 0.2
Median 52 54
3 d–100 y
8 mo–100 y

Race, no. (%)†
White 1,685 (82) 385 (80) 0.2
African American 158 (8) 33 (7) 0.5
Asian or Pacific Islander 58 (3) 16 (3) 0.6
Native American or Alaska Native 110 (5) 11 (2) <0.01
Other 37 (2) 37 (8) <0.01
1 (0)

Hispanic ethnicity, no. (%)‡ 319 (24) 63 (13) <0.01

*Sex data were available for only 5,601 reported coccidioidomycosis cases.
†In Arizona, race and ethnicity are recorded in separate variables. Therefore, race data do not include a specific category for Hispanic ethnicity but include Hispanics. Race is categorized as White, African American, Asian or Pacific Islander, Native American or Alaska Native, or Other. Race data were available for 2,048 reported coccidioidomycosis patients and for 483 enhanced surveillance patients.
‡In Arizona, race and ethnicity are recorded in separate variables. Ethnicity is categorized as either Hispanic or non-Hispanic. Ethnicity data were available for 1,345 coccidioidomycosis patients and for 482 enhanced surveillance patients.

Main Article

Page created: September 07, 2011
Page updated: September 07, 2011
Page reviewed: September 07, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.